Abstract
Background In late 2022, a surge of severe bacterial infections caused by S. pyogenes was reported in several European countries, including Germany. This study assessed disease burden and severity of hospitalizations for community-acquired bacterial infections with S. pyogenes, S. pneumoniae, N. meningitidis, and H. influenzae among children in North Rhine-Westphalia (NRW), Germany, during the last quarter of 2022 compared to long-term incidences.
Methods Hospital cases due to bacterial infections between October and December 2022 were collected from 59/62 (95 %) children’s hospitals in NRW and combined with surveillance data (2016 - 2023) from the national reference laboratories for streptococci, N. meningitidis, and H. influenzae. Total cases in NRW and incidence rates from January 2016 to March 2023 were estimated by capture-recapture analyses. Expected annual deaths from the studied pathogens were calculated from national death cause statistics.
Results Between October and December 2022, 153 cases with high overall disease severity were reported with pneumonia being most common (59 %, n = 91). Incidence rates of bacterial infections declined at the beginning of the COVID-19 pandemic. In late 2022 and early 2023 a massive surge to levels unprecedented since 2016 was observed, mainly driven by S. pyogenes and S. pneumoniae. Observed deaths during the study period exceeded the expected number for the entire year in NRW by far (7 vs. 0.9).
Discussion The unprecedented peak of bacterial infections in late 2022 and early 2023 was caused by various mechanisms intertwined that require close surveillance and improved precautionary measures for future outbreaks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Ethics Committee of the Medical Faculty of the University of Duisburg-Essen (22-11045-BO).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Conflict of Interest Disclosures (includes financial disclosures): The other authors have no conflicts of interest to disclose.
Funding/Support: This research received no external funding. The surveillance of invasive streptococcal infections in Germany at the German National Reference Laboratory for Streptococci was funded by the Robert Koch Institute, Berlin, Germany (funding number: 1369-235)
Role of Funder/Sponsor (if any): The funder had no role in the design and conduct of the study.
Clinical Trial Registration (if any) n/a
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- CI
- confidence interval
- CNS
- central nervous system
- CRC
- capture-recapture
- eCRF
- web-based case report forms
- ENT
- ears nose and throat
- FSO
- Federal State Office H. influenzae = Haemophilus influenzae
- ICD-10-GM
- international classification of diseases 10 German modification
- IQR
- interquartile range
- IRR
- incidence rate ratios
- MC
- multicentre study, N. meningitidis = Neisseria meningitidis,
- NRL
- National Reference Laboratories
- NRLMHi
- National Reference Laboratory for N. meningitidis and H. influenzae,
- NRW
- North Rhine-Westphalia
- PCPC
- pediatric cerebral performance category
- PICU
- pediatric intensive care unit
- rRNA
- ribosomal Ribonucleic acid
- RSV
- respiratory syncytial virus, S. pneumoniae = Streptococcus pneumoniae, S. pyrogenes = Streptococcus pyogenes,
- SIRS
- systemic inflammatory response syndrome
